Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Cloud-Based Digital Solution Allows Labs to Track Test Samples along Entire Diagnostic Journey

By LabMedica International staff writers
Posted on 23 May 2023

Diagnosing a disease involves a meticulous procedure of monitoring a patient's diagnostic sample throughout its entire journey, which aids in clinical decision-making. However, there aren't any standardized systems that address this need comprehensively. The majority of the errors with patient samples usually happen during the pre-pre-analytical (PPA) phase — the collection, transport, and receipt of samples like blood, urine, etc. This phase often falls outside the lab's jurisdiction. Errors, leading to a need for re-sampling, can cause patients discomfort, reduced trust, and possible delays in treatment. For labs, re-sampling escalates operational costs and hampers productivity. In hospitals across North America and Europe, a single pre-analytical error costs around USD 208 on average. To address this, a new digital solution allows labs to connect to innovative applications that monitor quality and spot errors in patient test samples throughout the entire journey of the patient's sample to the lab.

Roche (Basel, Switzerland) has launched navify Sample Tracking — a cloud-based digital solution aimed at helping labs tackle the unique quality issues that may arise during the journey of a diagnostic test sample, usually outside the lab. navify Sample Tracking allows lab managers to have better control by accessing and merging innovative applications to customize and scale the solution to fit their lab's specific requirements. It also aids lab managers in tracking and assessing the quality of diagnostic test samples right from the outset, before the samples even reach the lab. This solution connects the lab directly with PPA solution providers and the lab's information system (LIS), along with the middleware cobas infinity lab, for a swift and secure integration of PPA innovation into any laboratory workflow.

Roche's navify digital solutions empower healthcare systems to integrate data streams across labs and point-of-care operations. This digital infrastructure connects Roche and non-Roche solutions, facilitating secure data integration at scale. navify solutions are designed with a certified, secure-by-design cloud architecture that has multiple layers of robust cybersecurity, ensuring compliance with data privacy regulations, as data security and interoperability are major challenges that labs face today. Moreover, Roche's integrated navify solution portfolio aids labs in managing staff shortages while improving turnaround times and operational efficiency in the lab and at points of care. Among the newly-introduced solutions are navify Control, a command cockpit that offers lab managers remote control within the lab for swift decision-making, especially in response to operational issues. navify Monitoring provides real-time transparency into lab operations. Lastly, navify Analytics empowers lab managers and point of care coordinators to optimize performance by using retrospective data to pinpoint opportunities for improving staffing service levels, process turnaround times, and quality.

"Labs have incredible possibilities today to digitally transform their operations using insights to improve quality and operational efficiencies, not just for the lab, but for the entire healthcare system. More importantly, patients benefit when we can reduce sample errors from the start. For example, if a new sample is needed due to an error, the patient may experience uncertainty waiting for decisions that are time critical and even possible delays in diagnosis or treatment," said Moritz Hartmann, Head of Roche Information Solutions at Roche Diagnostics. "By working together, as a strategic partner with deep healthcare expertise combined with our flexible, scalable navify portfolio of integrated digital solutions, we believe labs can play a pivotal role in shaping the future of healthcare."

Related Links:
Roche

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
New
H.pylori Test
Humasis H.pylori Card
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.